EGFRvIII vaccine in glioblastoma: nACT-IVe or not ReACTive enough?
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
19 October 2017
|
| In: |
Neuro-Oncology
Year: 2017, Volume: 19, Issue: 11, Pages: 1425-1426 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nox167 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1093/neuonc/nox167 Verlag, Volltext: http://academic.oup.com/neuro-oncology/article/19/11/1425/4557888 
|
| Author Notes: | Michael Platten |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572584807 | ||
| 003 | DE-627 | ||
| 005 | 20220814131200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180503s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/nox167 |2 doi | |
| 035 | |a (DE-627)1572584807 | ||
| 035 | |a (DE-576)502584807 | ||
| 035 | |a (DE-599)BSZ502584807 | ||
| 035 | |a (OCoLC)1341008213 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 245 | 1 | 0 | |a EGFRvIII vaccine in glioblastoma |b nACT-IVe or not ReACTive enough? |c Michael Platten |
| 264 | 1 | |c 19 October 2017 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.05.2018 | ||
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 19(2017), 11, Seite 1425-1426 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a EGFRvIII vaccine in glioblastoma nACT-IVe or not ReACTive enough? |
| 773 | 1 | 8 | |g volume:19 |g year:2017 |g number:11 |g pages:1425-1426 |g extent:2 |a EGFRvIII vaccine in glioblastoma nACT-IVe or not ReACTive enough? |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/neuonc/nox167 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://academic.oup.com/neuro-oncology/article/19/11/1425/4557888 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180503 | ||
| 993 | |a Editorial | ||
| 994 | |a 2017 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |e 60000PP121627780 |e 62700PP121627780 |k 0/60000/ |k 1/60000/62700/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1572584807 |e 3007833043 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1572584807","note":["Gesehen am 03.05.2018"],"language":["eng"],"person":[{"display":"Platten, Michael","given":"Michael","role":"aut","roleDisplay":"VerfasserIn","family":"Platten"}],"relHost":[{"id":{"eki":["357167341"],"zdb":["2094060-9"],"issn":["1523-5866"]},"note":["Gesehen am 21.07.23"],"part":{"volume":"19","issue":"11","text":"19(2017), 11, Seite 1425-1426","pages":"1425-1426","extent":"2","year":"2017"},"recId":"357167341","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1999 -"],"title":[{"title":"Neuro-Oncology","title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology"}],"disp":"EGFRvIII vaccine in glioblastoma nACT-IVe or not ReACTive enough?Neuro-Oncology","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Oxford ; Durham, NC","dateIssuedKey":"1999","publisher":"Oxford Univ. Press ; Duke University Medical Center","dateIssuedDisp":"1999-"}]}],"name":{"displayForm":["Michael Platten"]},"physDesc":[{"extent":"2 S."}],"id":{"eki":["1572584807"],"doi":["10.1093/neuonc/nox167"]},"origin":[{"dateIssuedDisp":"19 October 2017","dateIssuedKey":"2017"}],"title":[{"subtitle":"nACT-IVe or not ReACTive enough?","title":"EGFRvIII vaccine in glioblastoma","title_sort":"EGFRvIII vaccine in glioblastoma"}]} | ||
| SRT | |a PLATTENMICEGFRVIIIVA1920 | ||